Showing results (71-80 of 90) with videos related to
Sort By:
Pageof 9
International Journal of Molecular Sciences|February 14, 2015
Tumor immunotargeting using innovative radionuclidesFrançoise Kraeber-Bodéré, Caroline Rousseau, Caroline Bodet-Milin, et al.EJNMMI Research|January 5, 2012
Syndecan-1 antigen, a promising new target for triple-negative breast cancer immuno-PET and radioimmunotherapy. A preclinical study on MDA-MB-468 xenograft tumorsCaroline Rousseau, Anne Lise Ruellan, Karine Bernardeau, et al.Plos One|October 4, 2011
A monoclonal antibody to O-acetyl-GD2 ganglioside and not to GD2 shows potent anti-tumor activity without peripheral nervous system cross-reactivityNidia Alvarez-Rueda, Ariane Desselle, Denis Cochonneau, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 4, 2006
Targeting, toxicity, and efficacy of 2-step, pretargeted radioimmunotherapy using a chimeric bispecific antibody and 131I-labeled bivalent hapten in a phase I optimization clinical trialFrançoise Kraeber-Bodéré, Caroline Rousseau, Caroline Bodet-Milin, et al.Oncotarget|June 26, 2018
Sensitivity of pretargeted immunoPET using <sup>68</sup>Ga-peptide to detect colonic carcinoma liver metastases in a murine xenograft model: Comparison with <sup>18</sup>FDG PET-CTFanny Foubert, Sébastien Gouard, Catherine Saï-Maurel, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 28, 2016
Immuno-PET Using Anticarcinoembryonic Antigen Bispecific Antibody and 68Ga-Labeled Peptide in Metastatic Medullary Thyroid Carcinoma: Clinical Optimization of the Pretargeting Parameters in a First-in-Human TrialCaroline Bodet-Milin, Alain Faivre-Chauvet, Thomas Carlier, et al.Frontiers in Medicine|June 20, 2019
Clinical Results in Medullary Thyroid Carcinoma Suggest High Potential of Pretargeted Immuno-PET for Tumor Imaging and Theranostic ApproachesCaroline Bodet-Milin, Clément Bailly, Yann Touchefeu, et al.Seminars in Oncology|December 3, 2014
Radioimmunoconjugates for the treatment of cancerFrançoise Kraeber-Bodéré, Caroline Bodet-Milin, Caroline Rousseau, et al.Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|March 6, 2012
Dosimetry results suggest feasibility of radioimmunotherapy using anti-CD138 (B-B4) antibody in multiple myeloma patientsCaroline Rousseau, Ludovic Ferrer, Stéphane Supiot, et al.Cancers|December 10, 2021
Copper-64-Labeled 1C1m-Fc, a New Tool for TEM-1 PET Imaging and Prediction of Lutetium-177-Labeled 1C1m-Fc Therapy Efficacy and SafetyJudith Anna Delage, Silvano Gnesin, John O Prior, et al.Pageof 9